Postmenopausal Breast Cancer: What Every Woman Should Know

Postmenopausal Breast Cancer: What Every Woman Should Know

Breast cancer is the most common cancer diagnosed in women and the second most common cause of death from cancer among women worldwide. As women age, the risk of breast cancer naturally increases, especially after menopause. In fact, more than 90% of breast cancer cases occur in women over 40, with the highest numbers seen in those between 75 and 79 years old.

So, what’s the link between menopause and breast cancer?

It boils down to hormone exposure. During reproductive years, the body produces estrogen and progesterone, hormones that help regulate the menstrual cycle, but also stimulate breast cell growth. Over time, repeated cell division increases the chances for DNA errors, which may lead to cancer.

Women who experience menopause later (after age 55) are at higher risk, simply because they’ve had longer exposure to these hormones.

Another key factor is Menopausal Hormone Therapy (MHT) — commonly used to ease symptoms like hot flashes. However, studies show that combination MHT (estrogen + progesterone) may increase breast cancer risk, especially with long-term use or daily progesterone. It can also make mammograms less effective by increasing breast density.

In contrast, estrogen-only MHT is generally considered safer, especially for those who have had a hysterectomy.

How to Lower Your Risk? Preventive steps can go a long way:

- Maintain a healthy weight

- Exercise regularly

- Limit alcohol intake

- Go for regular screenings and mammograms

- Discuss MHT options with your doctor

For added support, consider a natural supplement like NatureRich® Borage Black Seed Plus. Rich in Omega 3, 6 & 9 from Borage Oil, Black Seed Oil, Flaxseed Oil, and Astaxanthin, it helps regulate hormonal balance, especially during perimenopause and menopause — potentially reducing long-term health risks.

Because caring for your hormones is caring for your future. 

Reference: Watkins EJ. Overview of breast cancer. JAAPA. 2019 Oct;32(10):13-17.